Antibiotic use for common cold
Antibiotics do not help patients with an uncomplicated common cold. Antibiotics can have side effects for the individual taking them that range from unpleasant to serious, even lethal. Antibiotic use also contributes to communal harm by encouraging antibiotic resistance. If there can be no benefit, but there can be harm, why is the common cold the commonest reason for doctors to prescribe antibiotics? We note that antibiotics are also overused in other conditions and other medical disciplines, as well as in agriculture and the food industry. The harm caused by antibiotics ranges from mild gastrointestinal disturbance to death. Reasons for overuse of antibiotics to treat the common cold include patient expectations, patient and doctor uncertainty around diagnosing complications of the common cold, and the pressure on the doctor to ‘do something doctor — anything’. Strategies to limit inappropriate antibiotic use are explored, particularly the use of ‘delayed prescriptions’, and evidence is presented that with education of doctors and patients the overuse can be reduced.
KeywordsChronic Obstructive Pulmonary Disease Sore Throat Rheumatic Fever Acute Respiratory Infection Common Cold
Unable to display preview. Download preview PDF.
- 1.Silverman W (1998) Where’s the Evidence? Debates in Modern Medicine. Oxford University Press, OxfordGoogle Scholar
- 2.Arroll B, Kenealy T (2005) Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database of Systematic Reviews: Art. No.: CD000247Google Scholar
- 5.Kenealy T (2007) Sore throat. In: F Godlee (ed): Clinical Evidence. BMJ Publishing Group, London, 597–599Google Scholar
- 7.Smucny J, Fahey T, Becker L et al. (2000) Antibiotics for acute bronchitis. Cochrane Database of Systematic Reviews CD000245Google Scholar
- 10.Arroll B, Keneally T (2006) Are antibiotics effective for acute purulent rhinitis? Systematic review and meta-analysis of placebo controlled randomised trials. BMJ doi: 10.1136/bmj.38891.681215.AEGoogle Scholar
- 15.Marwick J, Grol R, Borgiel A (1992) Quality Assurance for Family Doctors. WONCA, Jolimont, AustraliaGoogle Scholar
- 31.Pharmaceutical Management Agency (2003) Annual Review 2003. Pharmaceutical Management Agency (PHARMAC), WellingtonGoogle Scholar
- 32.Heffernan H (2002) Annual summaries in bacteriology. Lablink 10:9Google Scholar
- 33.Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, Huovinen P, for The Finnish Study Group for Antimicrobial Resistance (1997) The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 337:441–446CrossRefPubMedGoogle Scholar
- 36.Finch R, Metlay J, Davey P, Baker L, International Forum on Antibiotic Resistance colloquium (2002) Educational interventions to improve antibiotic use in the community: Report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect Dis 4:44–53CrossRefGoogle Scholar
- 43.Arroll B, Goodyear-Smith F (2003) Delayed prescriptions: Evolution of an innovation. N Z Fam Physician 30:30–34Google Scholar
- 45.Arroll B (2007) Upfront: The Augmentin free office. BPAC:6–8Google Scholar